Gut Flora Differs in Patients With Epilepsy and Cognitive Dysfunction
By Lori Solomon HealthDay Reporter
WEDNESDAY, Oct. 16, 2024 -- There is an imbalance in the gut flora of patients with epilepsy compared with healthy controls, according to a study published online Sept. 28 in the Journal of Health, Population and Nutrition.
BingCong Hong, from the Quanzhou First Hospital Affiliated to Fujian Medical University in China, analyzed differences in gut flora between patients with epilepsy with and without cognitive impairment (62 and 38 patients, respectively) and normal controls (100 controls).
The researcher found more significant differences in the structure and composition of the gut flora between patients in the epilepsy group and the control group but no significant differences in a diversity analysis (P > 0.05). Actinobacteriota, Faecalibacterium, and Collinsella were significantly lower in the group with cognitive impairment than the group without (P < 0.05), while the Alpha diversity index was numerically slightly smaller than that seen in the no cognitive impairment group. Both epilepsy groups had a more dispersed situation. Glycolysis and heterolactic fermentation were upregulated in the group with cognitive impairment. Collinsella, Oscillospirales, and Ruminococcaceae, markers for the presence or absence of comorbid cognitive impairment, had a greater impact on epilepsy combined with cognitive impairment.
“Gut flora could be an important factor in the evaluation of cognitive impairment in combination with epilepsy,” Hong writes.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2024
Read this next
Annual Wasteful Spending on Lecanemab Estimated at $133 to $336 Million
FRIDAY, Oct. 18, 2024 -- Annual wasteful spending on discarded lecanemab is anticipated to range between $133 and $336 million, given current vial sizes, according to a research...
Single-Substance Exposures Causing Seizures Increased in U.S. Children, 2009 to 2023
FRIDAY, Oct. 18, 2024 -- Seizures associated with pediatric single-substance exposures are steadily increasing, according to a study presented at the European Emergency Medicine...
Retinal Neuroaxonal Loss Detectable With Epilepsy
THURSDAY, Oct. 17, 2024 -- In people with epilepsy, progression of retinal neuroaxonal loss is detectable at short-term follow-up, according to a study published online Oct. 9...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.